Tarik Esen

Tarik Esen

Auto-generated profile, based on publicly available information

Tarik Esen

School of Medicine, Koc University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in European Urology Focus
Verified
Journal Article
Closed access
TETarık Esen
Tarık Esen
MKMert Kılıç
Mert Kılıç
HSHülya Seymen
Hülya Seymen
ÖAÖmer Acar
Ömer Acar
MDMehmet Onur Demirkol
Mehmet Onur Demirkol

1 March 2021 in European Urology Focus
Verified
Journal Article
Closed access
TETarik Esen
Tarik Esen
OFOkan Falay
Okan Falay
KTKayhan Tarim
Kayhan Tarim
AAAyse Armutlu
Ayse Armutlu
EKErsin Koseoglu
Ersin Koseoglu
DTDerya Tilki
Derya Tilki

21 December 2022 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
SCSevilay Senol Celik
Sevilay Senol Celik
ZÖZeliha Özdemir
Zeliha Özdemir
ACAbdullah Erdem Canda
Abdullah Erdem Canda
TETarik Esen
Tarik Esen

9 November 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ÖAÖmer Acar
Ömer Acar
EÖEzgi Özkurt
Ezgi Özkurt
GDGulfem Demir
Gulfem Demir
HSHilal Saraç
Hilal Saraç
CACan Alkan
Can Alkan
NLNathan A. Lack
Nathan A. Lack
Synchronous multifocal tumours are commonly observed in urothelial carcinomas of the bladder. The origin of these physically independent tumours has been proposed to occur by either intraluminal migration (clonal) or spontaneous transformation of multiple cells by carcinogens (field effect). It is unclear which model is correct, with several studies supporting both hypotheses. A potential cause of this uncertainty may be the small number of genetic mutations previously used to quantify the relationship between these tumours. To better understand the genetic lineage of these tumours we conducted exome sequencing of synchronous multifocal pTa urothelial bladder cancers at a high depth, using multiple samples from three patients. Phylogenetic analysis of high confidence single nucleotide variants (SNV) demonstrated that the sequenced multifocal bladder cancers arose from a clonal origin in all three patients (bootstrap value 100 %). Interestingly, in two patients the most common type of tumour-associated SNVs were cytosine mutations of TpC* dinucleotides (Fisher’s exact test p < 10−41), likely caused by APOBEC-mediated deamination. Incorporating these results into our clonal model, we found that TpC* type mutations occurred 2-5× more often among SNVs on the ancestral branches than in the more recent private branches (p < 10−4) suggesting that TpC* mutations largely occurred early in the development of the tumour. These results demonstrate that synchronous multifocal bladder cancers frequently arise from a clonal origin. Our data also suggests that APOBEC-mediated mutations occur early in the development of the tumour and may be a driver of tumourigenesis in non-muscle invasive urothelial bladder cancer.


1 March 2020 in European Urology Focus
Verified
Journal Article
Closed access
MKMert Kilic
Mert Kilic
MVMetin Vural
Metin Vural
BCBilgen Coskun
Bilgen Coskun
ÖAÖmer Acar
Ömer Acar
YSYesim Saglican
Yesim Saglican
TETarik Esen
Tarik Esen